Introduction
Iron chelation or disruption of iron acquisition by tumor cells is under active investigation as a therapeutic approach in the treatment of some cancers and free radical-mediated injury (Nocka and Pelus, 1988; Wang et al., 1999) . Treatment of cells with the iron chelator desferrioxamine mimics the eect of oxygen deprivation on a number of hypoxia responsive genes (Bunn and Poyton, 1999; An et al., 1998) . Desferrioxamine induces hypoxia-dependent gene expression, probably by replacing or removing the central iron of the putative heme oxygen sensor (Bunn and Poyton, 1999; Goldberg et al., 1988) .
Hypoxia inducible factor-1 (HIF-1), which activates the transcription of a number of genes may aid cells in adapting to a reduced oxygen supply, is a major component of the molecular response to hypoxia Semenza and Wang, 1992) . HIF-1 is composed of a and b subunits: the latter is constitutively expressed and was found to be a hydrocarbon receptor nuclear translocator (Wang et al., 1995) . Hypoxia results in stabilization of HIF-1a and, upon dimerization, it binds to the hypoxia responsive element in target genes, including erythropoietin and vascular endothelial growth factor (Semenza and Wang, 1992; Levy et al., 1995) . The genes encoding key glycolytic enzymes such as aldolase A, phosphoglycerate kinase 1, enolase 1, phosphofructokinase L, and lactate dehydrogenase A (LDHA) are also inducible, in a hypoxia-dependent manner (Firth et al., 1994; Semenza et al., 1994) . Investigations on cisacting sequences for the gene encoding LDHA indicated that there are multiple sites for HIF-1 binding in the 5'-¯anking region and that HIF-1 binding to one of the sites is essential for hypoxic activation of transcription (Semenza et al., 1994; Firth et al., 1995) . Interaction of the HIF-1 binding site with a cAMP-responsive element in the promoter is required for full activation (Firth et al., 1995) . Hypoxic induction of expression of the LDHA gene in many cell lines also occurs (Kambe et al., 1998) , however inducible expression of the erythropoietin gene was only found in erythropoietin-producing cells (Kambe et al., 1998) .
ZAC1, also known as PLAGL1, and PLAGL2 are members of the PLAG family . PLAG1 was originally discovered as a developmentally regulated C2H2 zinc ®nger gene on chromosome 8q12 and proved to be the main target for pleomorphic adenomas of the salivary gland (Kas et al., 1997a,b) . The largest cytogenetic subgroup of pleomorphic adenomas of the salivary gland has chromosome 8q12 aberrations with 3q21 as a preferential translocation partner . The ectopic expression of PLAG1 in tumors probably leads to an abnormal expression of the target gene involved in the causating of tumorigenesis . Human ZAC1 is a widely expressed zinc ®nger protein that shows transactivation and DNA-binding activity . Loss of expression of ZAC1 has been noted for a number of breast and ovarian carcinomas (Abdollahi et al., 1997) . In addition, heterologous expression of human ZAC1 into tumor cells demonstrated that human ZAC1, like its mouse counterpart and p53, inhibits tumor cell proliferation through induction of apoptosis and cell cycle arrest, thus indicating that ZAC1 may be a potential tumor suppressor gene. PLAGL2 also functions as a positive regulator of transcription , but the physiological roles of the protein have remained to be determined.
We isolated PLAGL2 cDNA under conditions of iron deprivation, as related to iron metabolism or hypoxia. For this we used subtraction cloning between mRNA from desferrioxamine-treated mouse Raw264.7 cell and from untreated cells. When expressed in mammalian cells, PLAGL2 localized in the nuclei. The protein speci®cally bound to the oligonucleotide containing ACGGGGGGCCCCTTTA sequence, and overexpression of PLAGL2 resulted in activation of transcription from the promoter containing the sequence. Increase in LDHA gene promoter activity with an enhanced response to hypoxia by the expression of PLAGL2 was also evident.
Results

Screening of iron-deficient inducible cDNA and isolation of PLAGL2 cDNA
To obtain clones related to iron de®cient-or hypoxiainducible genes, subtraction cDNA cloning was done with mRNA of desferrioxamine-treated (tester) and untreated RAW264.7 cells (driver), subtracting the latter from the former. Three rounds of hybridization and PCR ampli®cation were performed and 50 dierentially expressed products were cloned. The induction of mRNA in desferrioxamine-treated cells was assessed by Northern blotting. Of these clones, mRNAs of 22 clones were markedly induced by desferrioxamine treatment and the DNA sequences revealed that seven clones either repeatedly appeared or overlapped. Finally four clones were unknown genes and eight were known genes, as shown in Table 1 . Among the cDNA fragments obtained, DFO27 with close homology to the 3'-uncoding region of human PLAGL2 cDNA was selected and full length cDNA (7 kb) 2 was obtained by the sequential screening, using mouse lung and liver cDNA libraries and PCR ampli®cation. Clone DFO27 was a mouse homolog of PLAGL2 previously reported to be a member of the PLAG superfamily . A PLAGL2 homolog, ZAC1 (PLAGL1), is a zinc-®nger protein which may inhibit tumor cell proliferation through induction of both apoptosis and cell cycle arrest. To compare the properties of PLAGL2 protein with those of ZAC1, the protein coding region of ZAC1 cDNA was also obtained.
Nucleotide and deduced amino acid sequences of mouse PLAGL2 and ZAC1 cDNAs Figure 1 shows structural features of PLAGL2 and ZAC1. Mouse PLAGL2 consists of 496 amino acids with a molecular mass of 55 kDa. The PLAGL2 contains seven C2H2 zinc ®ngers in the amino terminal region, and the identity to the human protein is 92%. At the middle of the protein, we noted STSY conserved motif, a potential phosphorylation site of tyrosine and serine/ threonine protein kinase. When compared to mouse ZAC1, the amino terminal half of PLAGL2, consisting of C2H2 zinc-®nger motifs, showed high homology (70%) and the remaining half toward the carboxy terminal of PLAGL2 lacks proline-repeated sequences and has a lesser degree of homology (20%). Both PLAGL2 and PLAG1 contain multiple zinc-®nger motifs. (t)BLAST search of public libraries revealed no other cDNAs with a close homology to any of the three PLAG family members described here.
Expression of PLAGL2 in mouse tissues and cell lines
When RAW267.4 cells were treated with 100 mM desferrioxamine, the PLAGL2 mRNA increased with time and reached at ®vefold over control after 24 h treatment (Figure 2a) . Induction of PLAGL2 mRNA was also observed in desferrioxamine-treated MEL cells and 3T3 cells (Figure 2b ). ZAC1 mRNA did not increase in desferrioxamine-treated RAW267.4 cells, Balb/c 3T3 cells or MEL cells (data not shown). Under hypoxic conditions, PLAGL2 mRNA was induced ( Figure 2c ). Figure 2d shows Northern blots of PLAGL2 in mouse tissues. PLAGL2 mRNA of about 6.8 kb was ubiquitously expressed in various tissues, with a relatively high expression in lung, spleen and testis.
Nuclear localization and DNA binding of PLAGL2
To determine the intracellular localization of mouse PLAGL2 we made use of immuno¯uorescence staining. As shown in Figure 3 , the nuclei of COS-7 cells expressing mouse PLAGL2 were strongly stained (a) and in mock treated control cells staining was nil (b). The N-terminal half of PLAGL2 contains multiple zinc-®ngers and has a high homology to human ZAC1, which was shown to preferentially bind to DNA containing consensus sequence of ACGGGGGCC-CCTTTA. We attempted to determine if mouse PLAGL2 also has DNA binding activity and binds to the same sequence and for this we used electrophoretic mobility shift assay. GST fusion protein of mouse PLAGL2 zinc-®nger region bound to double stranded oligonucleotides containing the consensus sequence but not to the one with a mutation ( Figure   4 , lanes 2 and 6). The presence of excess amounts of unlabeled consensus oligonucleotides greatly decreased binding to the labeled consensus oligonucleotide but the unlabeled mutated oligonucleotide showed little eect ( Figure 4 , lanes 2 ± 5). The zinc-®nger region of mouse ZAC1 showed binding characteristics similar to human ZAC1 and mouse PLAGL2 (Figure 4 , lanes 7 ± 11).
Transcriptional activation by mouse PLAGL2 or ZAC1
To determine if mouse PLAGL2 can function as a transcription factor, we constructed a luciferase reporter plasmid with four repeats of consensus binding sequence for ZAC1/PLAGL2, pGL3-BT-4B, and used it in reporter assays of cells transiently transfected with mouse PLAGL2 expressing plasmids. Transfection of increasing amounts of pCG-PLAGL2 (0.2 ± 1.6 mg) led to expression of increasing amounts of HA-tagged PLAGL2, as noted in Western blotting, using an anti-HA antibody and nuclear extracts from the transfected cells (data not shown). Transcription from the promoter containing the consensus ZAC1/ PLAGL2 binding sequence increased 9 ± 12-fold by Figure 1 Alignment of deduced amino acid sequence of full length mouse PLAGL2 with human PLAGL2 and mouse ZAC1. Conserved residues among the polypeptides are shaded. The C2H2 consensus residues for zinc-®ngers are underlined expression of mouse PLAGL2 while the transcription from the control plasmid without the consensus sequence showed only a 1 ± 2-fold increase ( Figure  5a ). Transfection of pCG-ZAC1, which expresses mouse ZAC1, 9 ± 12-fold increased the transcription from the reporter plasmid containing the consensus sequence ( Figure 5b ). We then attempted to determine if the transcription from the promoter with ZAC1/ PLAGL2 binding sequence could be induced by irondepletion. Balb/c 3T3 cells were transfected with pSVb-galactosidase and pGL3-BT-4B or pGL3-BT and treated with 100 mM desferrioxamine for 16 h. The induction by desferrioxamine treatment was 1.40+0.17 times higher (n=6) in normalized transcription from pGL3-BT-4B relative to the transcription from the control pGL3-BT.
Effects of PLAGL2 or ZAC1 on transcription from the HIF-1 responsive element containing promoter
The promoter region of the LDHA gene contains HIF-1 responsive elements (Firth et al., 1995) . Under these conditions hypoxia transcription of the LDHA gene is induced through HIF-1 binding to the element. To investigate the possibility that PLAGL2 plays a role in transcriptional responses of cells to hypoxic conditions or to iron depletion, we did reporter assays using a plasmid with the LDHA promoter and Balb/c 3T3 cells transiently transfected with plasmid expressing mouse PLAGL2. Figure 6a shows results from experiments in which Balb/c 3T3 cells were co-transfected with LDHA reporter plasmid, pSV-b-galactosidase, and pCG-PLAGL2 and cultured for 16 h, with or without When the cells were treated with desferrioxamine, the increase in transcription became more prominent, 6 ± 42-fold, with increase in the amount of transfected pCG-PLAGL2. When the reporter plasmid with the mutated LDHA promoter was used instead of the one with the wild type LDHA promoter, transcription of the reporter also increased but the increase was 3 ± 10-fold in basic transcription and 4 ± 10-fold in activated transcription, with iron depletion. Increase in transcription from the LDHA promoter, but not the mutated promoter, by expression of PLAGL2 with concomitant augmentation of the activity by desferrioxamine treatment was also observed in HepG2 cells (Figure 6b ). Under hypoxic conditions, transfection of pCG-PLAGL2 in Balb/c 3T3 cells augmented transcription from the LDHA promoter ®ve to 12 times and that from mutated LDHA promoter six to nine times ( Figure 6c ). Expression of pCG-ZAC1 in 3T3 cells also led to a marked increase in the reporter activity of the LDHA promoter and that with a mutation (Figure 6d ).
Discussion
We did subtraction cloning of several candidate mRNAs induced in desferrioxamine-treated Raw264.7 cells. These consisted of the previously known cDNAs encoding glycolytic enzymes (Firth et al., 1994; Semenza et al., 1994) , ribosomal proteins (Ye and Conner, 1999) and the p300/CREB-binding protein (CBP)-binding protein (Bhattacharya et al., 1999) , and unknown cDNAs. We also isolated by desferrioxamine treatment PLAGL2 as an inducible protein. PLAGL2 mRNA was induced in iron-depleted RAW264.7, MEL and Balb/c 3T3 cells, and was also induced by hypoxia. PLAGL2 is a zinc ®nger protein and expression of PLAGL2 in Cos 7 cells resulted in exclusive localization in nuclei. PLAGL2 not only exhibited DNAbinding activity but also activated the reporter gene Figure 3 Nuclear localization of PLAGL2. Immunocytochemistry of COS-7 cells transfected with HA-tagged mouse PLAGL2 (2 mg plasmid) (a) and untransfected control (b) was done using an anti-HA antibody and a¯uorescent conjugated secondary antibody Figure 4 Sequence speci®c cDNA binding of GST-PLAGL2 and GST-ZAC1. An electrophoretic mobility-shift assay was done. GST fusion proteins of putative DNA-binding domains of PLAGL2 and ZAC1 were overexpressed in E. coli and puri®ed. One hundred ng of each protein was incubated with 32 P-labeled double-stranded oligonucleotide containing the consensus binding sequence (lanes 2 ± 5 and 7 ± 10), or mutated sequence (lanes 6 and 11). Unlabeled double-stranded oligonucleotide containing the consensus sequence (lanes 3, 4, 8 and 9) or the mutated sequence (lanes 5 and 10) was added as competitor 20 times (lanes 3 and 8) or 200 times (lanes 4, 5, 9, and 10) excess to the labeled probe. Importantly, transient transfection of PLAGL2 in Balb/c 3T3 cells and HepG2 cells increased basal reporter activity of the LDHA gene promoter carrying the HIF-1 responsive element and this reporter activity was further activated by desferrioxamine treatment or in condition of hypoxia. We propose that PLAGL2 may play an important role in regulating iron depletion-or hypoxia-inducible gene expression. The PLAGL2 protein contains seven zinc-®nger motifs at the amino-terminus, and which is highly conserved among the PLAG superfamily, including PLAG1 and ZAC1. Although the central region of mouse and human PLAGL2 resembles those of human ZAC1 (PLAGL1) and PLAG1 , mouse ZAC1 does contain a long proline-rich region, followed by the repeat of proline-glutamate, which is missing in PLAGL2. As the putative phosphorylation site of four amino acids (STSY) was found at the middle of PLAGL2, function of the protein may be regulated by tyrosine and serine/threonine kinases. The human PLAGL2, ZAC1 and PLAG1, but not mouse ZAC1, share many amino acids at the carboxy terminal . The carboxy-terminally truncated forms of these proteins showed a decrease in transcriptional activity in mammalian cells when tested as fusion proteins of GAL4-DNA binding domain and the carboxy-terminal region of PLAG family proteins . Thus, the carboxy-terminal region of PLAGL2 as well as that of other PLAG family proteins is important for transcriptional activation.
High homology in amino-terminal regions containing multiple zinc-®nger motifs occurs among PLAG family proteins. Amino acid sequences of the fourth, sixth and seventh zinc-®ngers of mouse PLAGL2 are almost identical to human ZAC1 of which the consensus binding sequence was determined by screening of a random oligonucleotide library (Varrault et al., 1998) . Considering the high homology between the two proteins, it is not surprising that mouse PLAGL2, along with mouse ZAC1, bound to the same sequence as human ZAC1, as shown in this present study. Furthermore, both mouse PLAGL2 and ZAC1 activated transcription from the promoter containing the consensus binding sequence to a similar level ( Figure 5 ). When examined as fusion proteins with the Gal4 DNA binding domain, human PLAGL2 showed a much weaker activation than human ZAC1 in COS-1 and 293 cells . As mouse and human PLAGL2 are highly homologous, dierences in the observed activation seem more likely to be derived from dierences in cell types used in the experiments and/or the dierences between using the protein as whole and using part of it as a fusion. In any case, we now have evidence that mouse PLAGL2 and ZAC1 can function as activators involved in the transcription of the LDHA promoter, which means that PLAGL2 and ZAC1 may share some of the functions of binding and activating the same promoter. However, it remains to be clari®ed which one of the cluster of putative zinc-®ngers of PLAGL2 and ZAC1 are critical for DNA recognition or to what extent their DNA binding preferences are similar.
In our transient transfection experiments, transcription from the LDHA promoter increased with the expression of PLAGL2 (Figure 6 ). The expression of PLAGL2 and ZAC1 increased the basal transcription from both wild type and mutated LDHA promoters in untreated control cells. When the cells were treated with desferrioxamine or kept in condition of hypoxia, activation of transcription from wild type LDHA promoter was augmented by co-expression of ) were carried out, except that pCG-ZAC1, expression vector for mouse ZAC1, was used instead of pCG-PLAGL2 PLAGL2: The increase was greater than the simple sum of the eect of PLAGL2 and HIF-1 response to iron-depletion or hypoxia. Thus, PLAGL2 and HIF-1 synergistically activate transcription of the LDHA promoter. Since transcription from the mutated LDHA promoter, which was mutated at the HIF-1 responsive element (Kambe et al., 1998) , also increased by PLAGL2, eect of PLAGL2 may be independent of the HIF-1 responsive element. The luciferase reporter plasmid containing the erythropoietin gene promoter and enhancer which also has the HIF-1 responsive element responded to the expression of PLAGL2, but to a lesser extent than did the LDHA promoter construct (Furukawa and Taketani, 2001, unpublished observation) . Although the region of the LDHA promoter and erythropoietin promoter/enhancer used The present study showed that PLAGL2 mRNA was ubiquitously expressed in various mouse tissues. Expression of mouse PLAGL2 but not mouse ZAC1 is markedly induced under iron-depleted and hypoxic conditions. Human ZAC1 is also widely expressed, but mouse ZAC1 is highly expressed only in the pituitary gland (Spengler et al., 1997) . Although dierences in the structure and range of expression of PLAG family proteins in human, rat and mice are intriguing, the wide range of expression suggests the possibility that PLAGL2 may play an integral and ubiquitous role in regulation of nuclear factors. A marked decrease in Lot1, a rat homolog of ZAC1, and human ZAC1 expression was observed in rat and human cell lines (Huang and Stallcup, 2000; Piras et al., 2000) . The chromosomal location of the human ZAC1 gene is 6q25, a region that has been implicated in the formation of various solid tumors (Zhang et al., 1997; Queimado et al., 1995) . Human PLAG1 is located at 8q12: two types of tumor-associated chromosomal translocation involving the PLAG1 gene result in ectopic expression of PLAG1 (Kas et al., 1997a) . Concurrent expression of p53 and ZAC1 in vivo might provide superior protection against neoplastic transformation and tumor progression (Varrault et al., 1998) . The increased or decreased expression of ZAC1 and related proteins is connected with a wide variety of tumors in humans and other mammals. Based on the structural similarity among PLAG family, iron-de®cient inducible PLAGL2 may also serve as a tumor suppressor.
Transfection of human and mouse ZAC1 inhibits growth of tumor cells through induction of apoptotic cell death and G1 arrest (Varrault et al., 1998) , which means that ZAC1 may share a function with p53. In this connection, hypoxia-mediated apoptosis of tumors in vivo requires p53 . Hypoxic induction of p53 requires the concomitant accumulation of HIF-1a for interaction of both proteins for reciprocal stabilization (Blagoskionny et al., 1997) . Furthermore, the interaction of p300/CBP with HIF-1a is essential for transcriptional responses to hypoxia (Arany et al., 1996) . On the other hand, a variant of mouse ZAC1, ZAC1b was separately found to be a binding protein of the nuclear receptor coactivator GRIP1 containing the basic helix ± loop ± helix and PAS (Per/Arnt/Sim) domain that are also found in subunits of HIF-1 (Huang and Stallcup, 2000) . Mouse ZAC1 can bind to CBP/p300 as well as to nuclear receptors (Huang and Stallcup, 2000) . Thus, the transcriptional complex formation and functions of ZAC1 closely resemble those of HIF-1 machinery, except that ZAC1 is not induced under hypoxic conditions. The present study demonstrates that PLAGL2 increases the basic transcriptional activity of the LDHA promoter which contains HIF-1 responsive element, and overexpression of PLAGL2 leads to a marked enhancement of the induction by desferrioxamine treatment or hypoxia. While the interaction of PLAGL2 with other adapter proteins remains unclear, based on structural and functional analogies among the PLAG family, iron-depletion inducible PLAGL2 may play an important role in transcriptional regulation in concert with HIF-1 under condition of hypoxia, as well as inhibition of proliferation of tumor cells by the hypoxia-induced activation of genes encoding the preapoptic proteins of Bcl-2 family (Bruick, 2000; Carmeliet et al., 1998) . Restriction enzymes and DNA modifying enzymes were from Takara Co. and Toyobo Co. RPMI 1640 medium and desferrioxamine were purchased from Sigma Chemicals Co. Fetal calf serum (FCS) and DMEM were from GIBCO-BRL Co. Monoclonal antibody for HA-1 (12CA5) and FITCconjugated goat anti-mouse immunoglobulin were obtained from Roche Molecular Biochemicals and American Qualex Antibodies, respectively. Multiple tissues of adult mice Northern blot membrane was a product of Clontech Co. All other chemicals were of analytical grade.
Materials and methods
Materials
Cell culture
Mouse macrophage cell line RAW264.7 was grown in RPMI1640 medium supplemented with 10% FCS (GIBCO-BRL) and antibiotics. Mouse erythroleukemia (MEL) cells, Balb/c 3T3 ®broblasts, and monkey kidney COS-7 cells were maintained in DMEM supplemented with 10% FCS and antibiotics. To decrease intracellular levels of iron, the cells were incubated in the medium in the presence of desferrioxamine (100 mM) for the indicated time. To maintain the state of hypoxia, the plates of cells were kept in an air-tight container with a packet of AnaeroPack for Cell, disposable O 2 absorbing and CO 2 generating agent (Mitsubishi Gas Chemical Co.), and under these conditions the O 2 concentration decreased to 2%.
Establishing subtracted cDNA libraries by subtraction hybridization
Total RNA was isolated from RAW264.7 cells (2610 7 ) cultured with or without 100 mM desferrioxamine for 16 h, and poly(A) + RNA was enriched using oligo(dT) cellulose, as described previously (Taketani et al., 1998) . Reverse transcription was done using 2 mg of mRNA from RAW264.7 cells cultured under the two conditions. The synthesized cDNA was cut with RsaI and ligated to adaptors included in the PCR-Selected cDNA Subtraction Kit (Clontech Co.) for purposes of subtraction hybridization. The subtraction was done to the cDNA from the iron depleted cells (tester) by that from the control cells (driver), according to manufacturer's instructions. The subtracted cDNA was ampli®ed by PCR. A further two rounds of hybridization and PCR ampli®cation were performed. After the third round of PCR ampli®cation, several bands were visible following electrophoresis in 1.2% agarose gel containing ethidium bromide. These individual bands were isolated and were directly ligated into pGEM-T vector (Promega Co.), which were transformed into JM101 cells. The white colonies were selected and the plasmids were isolated, followed by DNA sequencing.
Isolation of the full-length cDNA of mouse PLAGL2 and ZAC1
The 0.5 kb insert of the clone DFO27 was cut out, labeled with 32 P, and used as a probe for screening of a mouse lung cDNA library in lgt11. Six overlapping positive clones were obtained and sequenced. Using a primer at the 5' end region of the obtained sequence and another at the 3' end region of the mouse PLAGL2 sequence , the 1.0 kb fragment of the PLAGL2 cDNA from the carboxy terminal of the PLAGL2 protein coding region to the 3'-uncoding region was the ampli®ed by PCR using a cDNA template synthesized from mRNA isolated from desferrioxaminetreated RAW264.7 cells. The region previously reported to be mouse PLGL2 was PCR ampli®ed, using a Quick-Clone mouse liver cDNA library (Clontech). With two primers on the 5' end region of the mouse PLAGL2 , the 5' end was extended by 5'-RACE, using a Marathon-Ready mouse brain cDNA (Clontech) according to the manufacturer's instructions. The protein coding region of mouse ZAC1 was PCR ampli®ed using two primers and Quick-Clone mouse liver cDNA (Clontech) as a template. The obtained cDNAs were veri®ed by DNA sequencing, then analysed using computer software (GenetyxMac Software Development Co.).
Northern blot analysis
Total RNA was isolated from RAW264.7, Balb/c 3T3 and MEL cells (1610 7 ), using the guanidium isothiocyanate method, as described (Taketani et al., 1998) . Ten mg of RNA were loaded on a 1% agarose/formaldehyde gel, electrophoresed, transferred onto nylon membrane (Amersham, Hybond N+) for hybridization with the 32 P-labeled fragments of mouse PLAGL2 and ZAC1 cDNAs (Taketani et al., 1998) , then the ®lter was hybridized and washed, as described (Taketani et al., 1998) . Intensity of the bands was quanti®ed using an Advantec DMU-33c densitometer.
Plasmids
For bacterial expression of the putative DNA binding domain of PLAGL2, cDNA corresponding to the zinc®nger region of mouse PLAGL2 was PCR ampli®ed and subcloned into the BamHI-NotI site of an expression vector pGEX-4T-1 (Amersham-Pharmacia Co.) in the correct reading frame. The cDNA fragment of mouse ZAC1 corresponding to the zinc-®nger region was also PCR ampli®ed and inserted into pGEX-4T for bacterial expression. Zinc-®nger regions of PLAGL2 and ZAC1 were expressed as GST fusion protein in Escherichia coli JM109 and puri®ed on glutathione-Sepharose beads, according to Self and Hall (1995) .
For expression of mouse PLAGL2 in mammalian cells, we used the pCG-HA vector with HA-tag sequence (Kadota et al., 1997) . Two primers and PLAGL2 cDNA used as a template, the fragment of the protein coding region of PLAGL2 was ampli®ed and was digested with XbaI-HindIII then ligated into the XbaI-HindIII site of pCG-HA. Mouse ZAC1 cDNA was also inserted into the XbaI-HindIII site of pCG-HA for expression in mammalian cells.
Luciferase reporter plasmid with the TK promoter, pGL3-BT, was constructed by inserting the minimum TK promoter region into BglII-BamHI site of pGL3-basic plasmid (Promega). Double stranded oligonucleotides containing the consensus ZAC1 binding sequence (ACGGGGGGCCCCTT-TA) were phosphorylated, and ligated to each other then to the EcoRI site of pBluescript S/K+. The clone with four tandem repeats of consensus binding sequence was selected, the insert was cut out with SacI and KpnI and inserted into the SacI-KpnI site of pGL3-BT to produce pGL3-BT-4B. Luciferase reporter plasmids with the LDHA promoter region and its mutant were as reported (Kambe et al., 1998) .
Transient transfection and reporter assay
Mouse Balb/c 3T3 cells, and HepG2 cells (1610 6 cells) were placed in serum-free DMEM and transfected with 0.25 mg of reporter plasmids, 0.25 mg of pSV-b-galactosidase (Promega), and total 1.6 mg pCG-HA empty vector and pCG-PLAGL2, using transfection reagent Lipofectamine Plus (GIBCO-BRL) for 4 ± 5 h, according to the manufacturer's recommendations. The cells were then incubated in DMEM supplemented with 10% FCS and antibiotics, in the presence or absence of 100 mM desferrioxamine. The cells were collected at 16 h after the transfection and washed twice with phosphate-buered saline (PBS). The cells were then lysed in 100 ml of Reporter lysis buer (Promega), centrifuged and the supernatants were assayed for luciferase activity and for b-galactosidase activity. Luciferase assay was done according to the protocol for the Luciferase Assay System (Promega), and b-galactosidase activity for the b-galactosidase Assay System (ICN). Normalization for transfection eciency was done on the basis of bgalactosidase activity.
Electrophoretic mobility shift assay
Double stranded oligonucleotide 5'-GTACTAACGGGG-GGCCCCTTTAATCATC-3' containing the putative consensus binding sequence for ZAC1 (Varrault et al., 1998) , or a mutated sequence, 5'-GTACTAACGGGGGCGCCCTT-TAATCATC-3' (Varrault et al., 1998) , was end-labeled with g-32 P-ATP and T4 polynucleotide kinase. GST-PLAGL2 or GST-ZAC1 fusion protein was incubated with 32 P-labeled probes (10 000 c.p.m.) in reaction buer containing 25 mM HEPES, pH 7.9, 0.5 mM EDTA, 50 mM KCl, 10% glycerol, 0.5 mM DTT, 0.2 mM PMSF and 100 mg/ml poly(dI-dC)-poly(dI-dC), with or without competitors. Competitors used were the consensus binding sequence and the mutated sequence, as above. After a 30 min incubation at room temperature, the reaction mixture was loaded onto 4% polyacrylamide gels containing 50 mM Tris, 380 mM glycine, and 1 mM EDTA, pH 8.5, and electrophoresed at 150 V at 48C. The gels were then ®xed, dried, and exposed to an X-ray ®lm at 7808C. Protein concentration of the nuclear extracts was estimated according to Bradford (1976) .
Immunostaining of cells
Cells transfected with the indicated plasmids were plated on poly-L-lysine-coated glass coverslips. After a 16 h-culture period, the cells were washed three times with PBS and the adherent cells were ®xed, permealized and labeled with anti-HA-1 antibody (12CA5) and secondary antibodies, as described (Kadota et al., 1997) . Coverslips were washed, mounted and viewed under an Olympus LSM-GB200 confocal laser microscope (Olympus, Tokyo, Japan) (Mohri et al., 1999) .
